News
SCORR Marketing Named Agency of Record by Frenova Renal Research
SCORR Marketing, a global, strategic marketing and communications firm with concentrated expertise in drug discovery and development services, has been named agency of record for Frenova Renal Research.
Formerly known as the Clinical Studies Group of Fresenius Medical Care North America (FMCNA), Frenova is the only Phase I-IV drug and device clinical development services partner dedicated exclusively to renal research.
This singular focus allows Frenova to provide an intimate understanding of patients affected by kidney disease and its comorbid conditions, which ultimately positions Frenova to help treat and improve the quality of life for people with renal impairment.
“As the industry’s only dedicated renal contract research organization (CRO), Frenova Renal Research is providing something that other CROs can’t,” said Cinda Orr, president and CEO of SCORR Marketing. “We helped Frenova unveil its new name and brand identity at the recent Partnerships in Clinical Trials 2014 and are excited to develop strategies that will effectively support Frenova’s mission of improving the lives of those affected by a renal impairment.”
About SCORR Marketing
SCORR Marketing, a full-service marketing and communications firm, is dedicated to achieving results for its global clients by combining strategy and creativity. SCORR has locations across North America and Europe. For more information, visit www.scorrmarketing.com.